I guess my main point being the company has to give shareholders a reason to buy the stock and all this blaming of the shorts being the reason our stock drops is trying to find a scapegoat for the real issue.
After many setbacks progress is being made. It's not up to the speed of an instant gratification culture but with biopharma's having to deal with the government progress will always be incremental.
It isn't always shorts causing stock price drops but it happens often enough. In between times you have market maker manipulation and flippers to fill the gap. If you pay attention you can see there is a solid core of longs with less than 10% of shares actually in play. Which is why when the price stabilizes down and the shorts and flippers are out of play the price will rebound nicely.